Trial intelligence / Profile preview

Effects of improving oxygen concentration on dialysis-induced myocardial stunning – pilot study

2007-004012-31Phase 4Terminated

Sponsor
University Hospitals of Derby and Burton
Start
Apr 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of oxygen in chronic kidney disease (CKD) (2 arms), sponsored by University Hospitals of Derby and Burton. Primary endpoints: Frequency of myocardial stunning, Severity of myocardial stunning and 1 more. Started Apr 2009; status: terminated.

02

Drugs

oxygen
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on 2007-004012-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-004012-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call